LYTTON LAURENCE W 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 3:14 pm Purchase | 2022-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 16,081 4.990% | 2,155 (+15.47%) | Filing |
| 2022-02-14 7:44 pm Sale | 2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 13,926 6.600% | -1,887 (-11.94%) | Filing |
| 2021-02-16 11:26 am Purchase | 2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 15,813 9.990% | 7,805 (+97.45%) | Filing |